#VisualAbstract: Carfilzomib, dexamethasone, and lenalidomide superior to lenalidomide monotherapy for multiple myeloma
Click to read this study in The Lancet Oncology.
Source: 2minutemedicine.com
Fast, Ad-Free News Updates
Stay updated with breaking news from Hematologic Malignancy. Real-time updates on events, politics, business and more.